Collectively, we suggest a model in which PLCL1 promotes tumor cell “slimming” by increasing the level of UCP1, allowing cells to consume lipids without producing ATP to repress the progression of ccRCC (Figure 7G). This evidence concerns the gene UCP1 and nonpapillary renal cell carcinoma.